IMIDomics
Luisa Salter-Cid, Ph.D. is the chief scientific officer (CSO) at Pioneering Medicines where she is responsible for spearheading a portfolio of groundbreaking treatments. She was previously the CSO at Gossamer Bio and spent more than a decade at Bristol Myers Squibb. At Bristol Myers Squibb, she served as vice president and head of Immunology, Small Molecule Immuno-Oncology, and Genomics Discovery overseeing the development of therapeutics for autoimmune diseases and cancer.
This person is not in the org chart
This person is not in any offices
IMIDomics
IMIDomics, Inc. is a biotechnology company focused on the discovery and development of new medicines for the treatment of immune-mediated inflammatory diseases (IMIDs).